



































































































View Journal  | View IssueDesign of a goldaStudent Research Committee, Qazvin Unive
bMedical Microbiology Research Center,
Qazvin, Iran
cMedical Biotechnology Department, Fac
University of Medical Sciences, Qazvin, Iran
dMedical Microbiology Research Center,
Qazvin, Iran
† Electronic supplementary informa
10.1039/d0ra00848f
Cite this: RSC Adv., 2020, 10, 11590
Received 28th January 2020
Accepted 20th February 2020
DOI: 10.1039/d0ra00848f
rsc.li/rsc-advances
11590 | RSC Adv., 2020, 10, 11590–11nanoprobe for the detection of
Pseudomonas aeruginosa elastase gene (lasB)†
Alireza Farhangi,a Amir Peymanib and Hossien Ahmadpour-Yazdi *cd
Nosocomial infections are one of the major health problems that increase mortality. Pseudomonas
aeruginosa is one of the important causes of nosocomial infections. This bacterium has a gene called
the lasB gene, the product of which is a zinc-dependent metalloprotease. This gene plays a central role
in the pathogenesis of Pseudomonas spp. This pathogen is highly toxic and destroys tissues and also has
a moderating effect on the immune system; on the other hand, it initiates the intracellular pathway of
biofilm growth. Although there are methods such as molecular methods for identifying the lasB gene,
due to the high cost and the need for specialized personnel, it is necessary to replace them with an
appropriate method. In this study, a gold nanoparticle-based DNA diagnostic sensor sensitive to the
aggregation states of gold nanoparticles was used to identify amplified and non-amplified lasB genes.
The results of the experiment were evaluated both visually and spectrally. The minimum detection value
of this method was 10 ng of the amplified lasB gene and 50 ng of the non-amplified lasB gene. This
method is very fast, simple, easy and low cost.1 Introduction
Nosocomial infections have been one of the major health
problems for a long time, and they increase the mortality rate in
hospitalized patients. These infections have increased health
care costs.1 About 5% to 10% of hospitalized patients are
infected with a nosocomial infection.2 According to WHO
studies, the prevalence of nosocomial infections in developing
countries is between 5.7% and 19/1%, while it is 7/6% in
developed countries.3 According to the studies in Iran, the most
common bacteria that are isolated from patients with nosoco-
mial infections include Pseudomonas aeruginosa (24/3%), Kleb-
siella pneumoniae (18/6%) and enterobacteria (14/3%).1 The
genus Pseudomonas belongs to the family of Pseudomonada-
ceae and to the class of Pseudomonadales. Pseudomonas aeru-
ginosa is a ubiquitous Gram-negative opportunistic bacterium,4
which is the most important cause of nosocomial infections in
patients with weakened immune systems; Pseudomonas infec-
tions have led to a mortality rate of about 50% in these
patients.5–7 Pseudomonas aeruginosa is one of the most common
causes of lower respiratory tract infection. It has a gene calledrsity of Medical Sciences, Qazvin, Iran
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597lasB that produces a zinc-dependent metalloprotease called
Pseudomonas elastase or pseudolysin that plays a critical role in
the pathogenesis of Pseudomonas aeruginosa. This pathogen is
highly toxic and damages tissues and also has a moderating
effect on the immune system; on the other hand, it initiates the
intracellular pathway of biolm growth. These are the patho-
genic mechanisms of lasB that cause a chronic infection to
develop.8 To identify Pseudomonas aeruginosa bacteria, gram
staining and culture in different environments can be used,
which are time consuming and do not have high sensitivity and
specicity.9,10 lasB can be identied using other methods, such
as PCR and real-time PCR. These two methods, although highly
specic and sensitive, have limitations due to the requirement
of dedicated reagents, expensive equipment and specialized
personnel.11,12
Recently, researchers have shown great interest in using gold
nanoparticles to identify pathogens.13–20 This method of detec-
tion is based on the property of surface plasmon resonance
(SPR) of gold nanoparticles. The change in the dispersion state
of the nanoparticles results in a color change, which results in
detection.21,22 Many studies have used gold nanoparticles con-
taining thiol-modied oligonucleotides (Au nanoprobes) for
diagnosis.23 These nanoparticles have unique optical proper-
ties. These features enable us to visualize their color change and
thus, no advanced tools are needed in this method. These
nanoprobes can be used in two ways to identify nucleic acid
sequences using a cross-linking method (CL) and a non-cross-
linking method (NCL).21,23–25 In the NCL colorimetric assay,
attaching the complementary portion of the target molecule to
the nanoprobe makes the nanoprobes resistant to salt-inducedThis journal is © The Royal Society of Chemistry 2020
